DOI:
10.1055/s-00000011
DMW - Deutsche Medizinische Wochenschrift
LinksClose Window
References
Sitbon O, McLaughlin VV, Badesch DB et al.
Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol.
Thorax 2005;
60: 1025-1030
We do not assume any responsibility for the contents of the web pages of other providers.